Harvard Bioscience (HBIO) Deferred Taxes (2010 - 2019)
Harvard Bioscience (HBIO) reported Deferred Taxes of $42000.0 for Q3 2019, down 74.07% year-over-year from $162000.0 in Q3 2018, and up 4300.0% quarter-over-quarter from -$1000.0 in Q1 2019.
Harvard Bioscience (HBIO) Deferred Taxes (2010 - 2019) Analysis & Trends
Harvard Bioscience (HBIO) has 10 years of Deferred Taxes data on file, last reported at $42000.0 in Q3 2019.
- Deferred Taxes for Q3 2019 came in at $42000.0, down 74.07% year-over-year; the trailing twelve-month figure through Sep 2019 was -$2.9 million (down 90.12% YoY), and the FY2018 annual result was -$2.9 million, down 80.62% from the prior year.
- Deferred Taxes improved to $42000.0 in Q3 2019 per HBIO's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $16.1 million in Q4 2015 and troughed at -$2.9 million in Q4 2018.
- A 5-year average of $745214.3 and a median of $1000.0 in 2015 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2015 and 2016: Deferred Taxes slumped 1019.05% in 2015, then jumped 14933.33% in 2016.
- A 5-year view of Deferred Taxes shows it stood at $16.1 million in 2015, then slumped by 104.55% to -$734000.0 in 2016, then plunged by 115.8% to -$1.6 million in 2017, then plunged by 84.79% to -$2.9 million in 2018, then surged by 101.43% to $42000.0 in 2019.
- Business Quant data shows HBIO's Deferred Taxes at $42000.0 in Q3 2019, -$1000.0 in Q1 2019, and -$2.9 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -339.30 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -73.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 37.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -41.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 43.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 40.64 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 29.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 42,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Dec 31, 2018 | -2.93 Mn |
| Sep 30, 2018 | 162,000.00 |
| Jun 30, 2018 | 1.26 Mn |
| Mar 31, 2018 | -1.35 Mn |
| Dec 31, 2017 | -1.58 Mn |
| Dec 31, 2016 | -734,000.00 |
| Sep 30, 2016 | 451,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 16.14 Mn |
| Sep 30, 2015 | 3,000.00 |
| Jun 30, 2015 | -772,000.00 |
| Mar 31, 2015 | -255,000.00 |
| Dec 31, 2014 | 1.15 Mn |
| Sep 30, 2014 | 140,000.00 |
| Jun 30, 2014 | 84,000.00 |
| Mar 31, 2014 | 35,000.00 |
| Dec 31, 2013 | -729,000.00 |
| Sep 30, 2013 | -411,000.00 |